Pinebridge Investments L.P. Acquires 26,836 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Pinebridge Investments L.P. raised its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 38.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 95,849 shares of the company's stock after acquiring an additional 26,836 shares during the period. Pinebridge Investments L.P.'s holdings in HCA Healthcare were worth $28,769,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Congress Wealth Management LLC DE boosted its holdings in HCA Healthcare by 3.4% in the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after purchasing an additional 34 shares during the last quarter. Evergreen Private Wealth LLC grew its position in shares of HCA Healthcare by 0.3% during the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock worth $3,838,000 after buying an additional 35 shares in the last quarter. Mediolanum International Funds Ltd boosted its stake in HCA Healthcare by 0.3% during the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock valued at $3,153,000 after acquiring an additional 36 shares during the last quarter. Prairie Wealth Advisors Inc. increased its position in shares of HCA Healthcare by 6.1% in the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock worth $210,000 after purchasing an additional 40 shares during the last quarter. Finally, Whittier Trust Co. grew its stake in HCA Healthcare by 3.6% in the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock worth $359,000 after purchasing an additional 41 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Down 4.0 %

Shares of HCA stock traded down $13.72 on Friday, hitting $327.69. The company's stock had a trading volume of 2,803,570 shares, compared to its average volume of 1,398,028. The firm's fifty day moving average price is $329.82 and its 200-day moving average price is $332.52. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The stock has a market capitalization of $80.68 billion, a price-to-earnings ratio of 14.92, a P/E/G ratio of 1.10 and a beta of 1.48.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating analysts' consensus estimates of $5.77 by $0.68. The business had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the prior year, the business earned $5.36 earnings per share. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.88%. HCA Healthcare's payout ratio is 13.11%.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company's stock, valued at $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts have recently commented on HCA shares. Truist Financial decreased their target price on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. KeyCorp dropped their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a report on Tuesday, January 7th. Guggenheim started coverage on shares of HCA Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating for the company. Royal Bank of Canada decreased their target price on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research note on Monday, January 27th. Finally, Barclays cut their price target on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare has an average rating of "Moderate Buy" and an average target price of $381.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.